Cargando…

Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)

OBJECTIVE: To evaluate, with real world data (SIDIAP and CMBD), the evolution of the prevalence of peripheral arterial disease (PAD) in the Catalan population and the cardiovascular risk factors present in people with this pathology. DESIGN: Longitudinal descriptive population study. SITE: Primary h...

Descripción completa

Detalles Bibliográficos
Autores principales: Forés, Rosa, Alzamora, María Teresa, Boixadera-Planas, Ester, Vázquez, Ana, Pera, Guillem, Torán, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399170/
https://www.ncbi.nlm.nih.gov/pubmed/35964545
http://dx.doi.org/10.1016/j.aprim.2022.102437
_version_ 1784772464739352576
author Forés, Rosa
Alzamora, María Teresa
Boixadera-Planas, Ester
Vázquez, Ana
Pera, Guillem
Torán, Pere
author_facet Forés, Rosa
Alzamora, María Teresa
Boixadera-Planas, Ester
Vázquez, Ana
Pera, Guillem
Torán, Pere
author_sort Forés, Rosa
collection PubMed
description OBJECTIVE: To evaluate, with real world data (SIDIAP and CMBD), the evolution of the prevalence of peripheral arterial disease (PAD) in the Catalan population and the cardiovascular risk factors present in people with this pathology. DESIGN: Longitudinal descriptive population study. SITE: Primary health care. PARTICIPANTS: Patients listed in SIDIAP and CMBD with a diagnosis of peripheral artery disease between 2008 and 2018 ≥ 35 years, as well as those without a diagnosis, but with an ABI < 0.9 in SIDIAP. INTERVENTIONS AND MAIN MEASUREMENTS: Main variable AP (ICD-9, ICD-10). Sociodemographic data, risk factors and cardiovascular disease, drug use and prevalent cardiovascular events at the time of diagnosis. RESULTS: 141,520 patients were studied. 75% had hypertension, 58% were smokers or former smokers, and 23% had a myocardial infarction. The global prevalence increased from 1.15% in 2008 to 3.10% in 2018. The prevalence of PAD increased with age, with a moderate increase at younger ages, and more pronounced in > 55 years, exceeding 10% in > 85 years. CONCLUSION: This is a population study where it is observed that the evolution of the prevalence of peripheral artery disease has presented a constant increase during the years 2008–2018, being higher in men, especially from 55 years of age. Studies with large databases can facilitate the design and implementation of new policies in national health systems.
format Online
Article
Text
id pubmed-9399170
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93991702022-08-25 Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD) Forés, Rosa Alzamora, María Teresa Boixadera-Planas, Ester Vázquez, Ana Pera, Guillem Torán, Pere Aten Primaria Original OBJECTIVE: To evaluate, with real world data (SIDIAP and CMBD), the evolution of the prevalence of peripheral arterial disease (PAD) in the Catalan population and the cardiovascular risk factors present in people with this pathology. DESIGN: Longitudinal descriptive population study. SITE: Primary health care. PARTICIPANTS: Patients listed in SIDIAP and CMBD with a diagnosis of peripheral artery disease between 2008 and 2018 ≥ 35 years, as well as those without a diagnosis, but with an ABI < 0.9 in SIDIAP. INTERVENTIONS AND MAIN MEASUREMENTS: Main variable AP (ICD-9, ICD-10). Sociodemographic data, risk factors and cardiovascular disease, drug use and prevalent cardiovascular events at the time of diagnosis. RESULTS: 141,520 patients were studied. 75% had hypertension, 58% were smokers or former smokers, and 23% had a myocardial infarction. The global prevalence increased from 1.15% in 2008 to 3.10% in 2018. The prevalence of PAD increased with age, with a moderate increase at younger ages, and more pronounced in > 55 years, exceeding 10% in > 85 years. CONCLUSION: This is a population study where it is observed that the evolution of the prevalence of peripheral artery disease has presented a constant increase during the years 2008–2018, being higher in men, especially from 55 years of age. Studies with large databases can facilitate the design and implementation of new policies in national health systems. Elsevier 2022-09 2022-08-11 /pmc/articles/PMC9399170/ /pubmed/35964545 http://dx.doi.org/10.1016/j.aprim.2022.102437 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original
Forés, Rosa
Alzamora, María Teresa
Boixadera-Planas, Ester
Vázquez, Ana
Pera, Guillem
Torán, Pere
Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)
title Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)
title_full Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)
title_fullStr Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)
title_full_unstemmed Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)
title_short Evolución de la prevalencia de arteriopatía periférica en la práctica clínica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)
title_sort evolución de la prevalencia de arteriopatía periférica en la práctica clínica: estudio descriptivo poblacional con bases de datos reales (sidiap-cmbd)
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399170/
https://www.ncbi.nlm.nih.gov/pubmed/35964545
http://dx.doi.org/10.1016/j.aprim.2022.102437
work_keys_str_mv AT foresrosa evoluciondelaprevalenciadearteriopatiaperifericaenlapracticaclinicaestudiodescriptivopoblacionalconbasesdedatosrealessidiapcmbd
AT alzamoramariateresa evoluciondelaprevalenciadearteriopatiaperifericaenlapracticaclinicaestudiodescriptivopoblacionalconbasesdedatosrealessidiapcmbd
AT boixaderaplanasester evoluciondelaprevalenciadearteriopatiaperifericaenlapracticaclinicaestudiodescriptivopoblacionalconbasesdedatosrealessidiapcmbd
AT vazquezana evoluciondelaprevalenciadearteriopatiaperifericaenlapracticaclinicaestudiodescriptivopoblacionalconbasesdedatosrealessidiapcmbd
AT peraguillem evoluciondelaprevalenciadearteriopatiaperifericaenlapracticaclinicaestudiodescriptivopoblacionalconbasesdedatosrealessidiapcmbd
AT toranpere evoluciondelaprevalenciadearteriopatiaperifericaenlapracticaclinicaestudiodescriptivopoblacionalconbasesdedatosrealessidiapcmbd